News



Life Technology™ Medical News

Researchers Develop Implantable Cytokine Factory for Cancer

Study: Long-Lasting Immune Response After Triple COVID Vaccination

Myasthenia Gravis: Muscle Weakness Impacting Daily Movements

Florida Scientists Discover Novel Pain-Activating Drug

Study Suggests Lower Tackle Height Cuts Rugby Head Collisions

Researchers Measure Neuronal Activity in Active vs. Passive Touch

Safety Evaluations of Agri-Food Additives in Processed Products

Managing Bacterial Infections: The Power of Antibiotics

Mental Health Challenges in Workplace: Funding Impact

Study Reveals Link: Hearing-Impaired Kids' Reading Woes Impact Mental Health

Survey Reveals High Occupational Stress Among Educational Psychologists

Melbourne Researchers Develop World-First Gender Euphoria Scale

Pediatric Dentistry Specialist: Preventing Common Tooth Decay

Study Reveals Potential of Pulmonary Artery Denervation for Pulmonary Hypertension

New Drug Compound Prevents Long Covid Symptoms in Mice

Netherlands Institute for Neuroscience Uncovers MS Treatment Targets

Medicine Students Lead Study on Cardioprotective Glucose-Lowering Therapies

Study Reveals Disparities in Active Life Expectancy

Boston Children's Hospital Study Reveals Fetal MRI Impact on VOGM Prediction

Study Reveals Surprising Link Between Fat Suppression and Cardiovascular Health

Cleveland Clinic Trial Shows 31% Delay in SPMS Disability

Social Media Usage at Night: The Real Sleep Disruptor

Deadly Dengue Virus Spreading: Breakthrough Chip Model

Adolescent Diet Linked to Excessive Social Media Use

Chewing Difficulties Linked to Malnutrition Risk

Experimental Drug NU-9 Boosts Neuron Health in Alzheimer's Model

Study Reveals 26% Increased Risk of Hospitalization Diseases

Farmworkers' Health Insurance Boosts Profits

Natural Compound in Fruits & Vegetables: Potential ALS Treatment

Rotavirus Genome Variability Impacts Vaccine Efficacy

Life Technology™ Medical News Subscribe Via Feedburner Subscribe Via Google Subscribe Via RSS

Life Technology™ Science News

Creatures Use Mismatches for Complex Structures

Hidden Wildlife Diversity Unveiled by Drexel Study

New Machine-Learning Algorithm Reveals Human Biology Insights

"Need to Halt CO2 Emissions and Capture Existing Carbon"

Study Reveals Massive Rhino Herds in Ancient North America

Billions of Animals in Constant Motion: Global Wildlife Migration

Mit Neuroscientists Unveil Brain's Adaptive Response

Asteroid Impact Wiped Out Dinosaurs

China Approves World's Largest Hydropower Dam in Tibet

Lewes District Council Grants River Ouse Environmental Rights

Environmental Changes in Aotearoa New Zealand: Threats Ahead

Influences on Education of Autistic Youth

Higher Rates of CFS Contact Among First Nations Birthing Parents

Ancient DNA from Pyrenean Lake Suggests Early Human Fish Introduction

New AI Tool Identifies Public Attitudes Efficiently

Study Reveals Common Apathy Towards Climate Change

Negative Effects of Disrupted Circadian Rhythms

Discovering the Stunning North Coast of Peru

New Research Uncovers Universal Patterns in City Population Movements

Sperm Swimming Discovery Boosts Fertility

Baby Monkeys' Enhanced Facial Recognition Boosts Social Skills

Record Dairy Consumption in US Despite Falling Milk Intake

"New Interpretations: Tutankhamun's Tomb Ritual Objects Revealed"

Agronomists Advocate New Approach for Crop Yield Estimation

Crucial Clue Uncovered: Barrens Threaten Great Southern Reef

Norwegian Seabird Populations Face Mercury Threat

Study Reveals Step-by-Step Guide for Teaching Design Thinking

Rise of Social Media Pet Influencers

Study Reveals Lactic Acid Bacteria Boost Plant-Based Dairy Quality

Scientists Remote Detection of Invasive Asian Hornet Flight

Life Technology™ Science News Subscribe Via Feedburner Subscribe Via Google Subscribe Via RSS

Life Technology™ Technology News

Rise of Fake News: AI Makes Detection Harder

AI's Rogue Rampage: Movies Reflecting Humanity's Fear

How to Safely Prepare Devices for Recycling

Conservative Video of Pierre Poilievre Sparks Speculation

"Uganda's Boda Bodas: Going Electric for Cleaner Air"

Australia's Growing Reliance on Imported Oil

Congress Bans TikTok Over National Security Concerns

New Optical Receiver Restores Chaotic Signals in Free-Space Communication

Flexible Robot Developed for Rescue Missions and Medical Delivery

Byd Expects Record Profits in Q1 Amid Booming Sales

Instagram Tightens Safety Measures for Under-16 Users

Novel Membrane Design Enhances Proton Transport for Energy Harvesting

Preserving Your Most Prized Possessions in a Virtual World

Utsa Study Reveals Risks of AI in Software Development

82-Year-Old Rancher Repairs Amidst Wind Turbines

Trump Administration Tariffs Drive Apple Stock Down, Boost iPhone Sales

Global Electricity Generation Sees Solar Power Share Surge

Samsung Electronics Unveils Record First Quarter Sales

Construction Sector: Tackling Pollution Through Recycling

Understanding Perception of AI Creativity

New Quantum Technology Shields Internet Communication

Small Language Models Outperform Large Ones

Scientist Discovers Unusual Atomic Pattern in New Aluminum Alloy

Study Reveals Facial Expression Control for AR and VR

New Generation Air Pollution Sensors Enhance Accuracy

Cornell Tech Study: Reddit Communities Adapt to AI Content Surge

Stephen Hawking's Grave Warnings on Artificial Intelligence

Unveiling the Grand Scientific Challenges: Intelligence and Machines

AI: The Ultimate Disruptor in History

Ocean Waves: Massive Renewable Energy Potential

Life Technology™ Technology News Subscribe Via Feedburner Subscribe Via Google Subscribe Via RSS

Wednesday, 22 February 2023

FDA widens warning for contaminated eye products

The U.S. Food and Drug Administration (FDA) issued a warning to consumers Wednesday to stop buying and using Delsam Pharma's Artificial Eye Ointment due to potentially serious health risks. The ointment is marketed as a “cure-all” for a range of eye disorders, including dry eyes, cataracts, glaucoma, and styes, but the FDA has determined it is not safe for use. According to the FDA, Delsam Pharma's Artificial Eye Ointment contains two ingredients – trolamine and procaine hydrochloride – which have not been approved by the FDA for any medical use. These ingredients could cause serious side effects such as headache, confusion, mental changes, seizures, or difficulty breathing. Additionally, the product has not undergone any testing for safety or efficacy. The FDA urges consumers to immediately stop using Delsam Pharma's Artificial Eye Ointment and dispose of any remaining ointment. Consumers should also contact their healthcare provider if they have experienced any side effects from using the ointment. Consumers should be aware that not all products sold as “cure-alls” are safe or effective. The FDA recommends that people consult with their healthcare provider when considering the use of any health product, including eye ointments, in order to ensure they are using a safe and effective product. The U.S. Food and Drug Administration (FDA) has issued a warning to consumers to stop buying and using Delsam Pharma's Artificial Eye Ointment due to potentially serious health risks associated with the product. Marketed as a “cure-all” for a range of eye disorders, Delsam Pharma's Artificial Eye Ointment contains two ingredients – trolamine and procaine hydrochloride – that the FDA has determined are not safe for use. The FDA is concerned about the potential side effects of using Delsam Pharma's Artificial Eye Ointment, which include headache, confusion, mental changes, seizures, or difficulty breathing. Additionally, the product has not undergone any safety or efficacy testing, meaning that it is both potentially unsafe and ineffective. Passengers should immediately stop using Delsam Pharma's Artificial Eye Ointment and dispose of any remaining ointment. They should also contact their healthcare provider if they have experienced any side effects from using the ointment. When considering the use of any health product, including eye ointments, it is important to consult with a healthcare provider in order to ensure it is safe and effective. Products marketed as “cure-alls” are not always as safe or as effective as they claim to be, and consumers should be aware of the risks associated with using them. The FDA has identified a number of products available online that are unsafe or fraudulent, and the agency continues to work to prevent the sale and distribution of these products. Consumers should always be sure to purchase medical products from a trusted source and read all instructions before use. In light of the FDA's warning, it is essential for consumers to stop buying and using Delsam Pharma's Artificial Eye Ointment. This product has been found to contain two ingredients – trolamine and procaine hydrochloride – with potential serious health risks. Additionally, the product has not undergone any safety or efficacy testing, and consumers should be aware of the risks associated with it. If consumers have experienced any side effects while using Delsam Pharma's Artificial Eye Ointment, they should contact their healthcare provider immediately. Furthermore, consumers should be sure to consult with their healthcare provider before using any health product and read all instructions provided. The FDA also urges consumers to purchase medical products from a trusted source in order to ensure safety and efficacy. The FDA is committed to protecting the health and safety of consumers, and it aims to prevent the sale and distribution of unsafe or fraudulent products online. With the agency's warning to stop buying or using Delsam Pharma's Artificial Eye Ointment, consumers should be aware of the potential health risks associated with this product, as well as the risks associated with using products marketed as “cure-alls”.

https://www.lifetechnology.com/blogs/life-technology-medical-news/fda-widens-warning-for-contaminated-eye-products

Buy SuperforceX™